Literature DB >> 32394550

To legalize or not to legalize cannabis, that is the question!

Marta Di Forti1.   

Abstract

Year:  2020        PMID： 32394550      PMCID： PMC7214953          DOI： 10.1002/wps.20737

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  6 in total

1.  Higher average potency across the United States is associated with progression to first cannabis use disorder symptom.

Authors:  Brooke J Arterberry; Hayley Treloar Padovano; Katherine T Foster; Robert A Zucker; Brian M Hicks
Journal:  Drug Alcohol Depend       Date:  2018-12-17       Impact factor: 4.492

2.  Cannabis use in young people: the risk for schizophrenia.

Authors:  Paola Casadio; Cathy Fernandes; Robin M Murray; Marta Di Forti
Journal:  Neurosci Biobehav Rev       Date:  2011-04-16       Impact factor: 8.989

3.  Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study.

Authors:  Marta Di Forti; Arianna Marconi; Elena Carra; Sara Fraietta; Antonella Trotta; Matteo Bonomo; Francesca Bianconi; Poonam Gardner-Sood; Jennifer O'Connor; Manuela Russo; Simona A Stilo; Tiago Reis Marques; Valeria Mondelli; Paola Dazzan; Carmine Pariante; Anthony S David; Fiona Gaughran; Zerrin Atakan; Conrad Iyegbe; John Powell; Craig Morgan; Michael Lynskey; Robin M Murray
Journal:  Lancet Psychiatry       Date:  2015-02-25       Impact factor: 27.083

4.  Association Between Recreational Marijuana Legalization in the United States and Changes in Marijuana Use and Cannabis Use Disorder From 2008 to 2016.

Authors:  Magdalena Cerdá; Christine Mauro; Ava Hamilton; Natalie S Levy; Julián Santaella-Tenorio; Deborah Hasin; Melanie M Wall; Katherine M Keyes; Silvia S Martins
Journal:  JAMA Psychiatry       Date:  2020-02-01       Impact factor: 21.596

5.  Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state.

Authors:  Rosanna Smart; Jonathan P Caulkins; Beau Kilmer; Steven Davenport; Greg Midgette
Journal:  Addiction       Date:  2017-07-04       Impact factor: 6.526

6.  The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.

Authors:  Marta Di Forti; Diego Quattrone; Tom P Freeman; Giada Tripoli; Charlotte Gayer-Anderson; Harriet Quigley; Victoria Rodriguez; Hannah E Jongsma; Laura Ferraro; Caterina La Cascia; Daniele La Barbera; Ilaria Tarricone; Domenico Berardi; Andrei Szöke; Celso Arango; Andrea Tortelli; Eva Velthorst; Miguel Bernardo; Cristina Marta Del-Ben; Paulo Rossi Menezes; Jean-Paul Selten; Peter B Jones; James B Kirkbride; Bart Pf Rutten; Lieuwe de Haan; Pak C Sham; Jim van Os; Cathryn M Lewis; Michael Lynskey; Craig Morgan; Robin M Murray
Journal:  Lancet Psychiatry       Date:  2019-03-19       Impact factor: 77.056
  6 in total
  3 in total

Review 1.  Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses.

Authors:  Zeinab Breijyeh; Buthaina Jubeh; Sabino A Bufo; Rafik Karaman; Laura Scrano
Journal:  Toxins (Basel)       Date:  2021-02-05       Impact factor: 4.546

2.  How to improve the physical health of people with severe mental illness? A multicentric randomized controlled trial on the efficacy of a lifestyle group intervention.

Authors:  Mario Luciano; Gaia Sampogna; Mario Amore; Ileana Andriola; Pietro Calcagno; Claudia Carmassi; Valeria Del Vecchio; Liliana Dell'Osso; Giorgio Di Lorenzo; Barbara Gelao; Vincenzo Giallonardo; Alessandro Rossi; Rodolfo Rossi; Alberto Siracusano; Andrea Fiorillo
Journal:  Eur Psychiatry       Date:  2021-11-23       Impact factor: 5.361

3.  Mortality gap and physical comorbidity of people with severe mental disorders: the public health scandal.

Authors:  Andrea Fiorillo; Norman Sartorius
Journal:  Ann Gen Psychiatry       Date:  2021-12-13       Impact factor: 3.455
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.